1. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018 Subject(s): Cystic Fibrosis -- drug therapyCystic Fibrosis Transmembrane Conductance Regulator -- therapeutic useClinical Trials as TopicCost of IllnessCost-Benefit AnalysisCystic Fibrosis Transmembrane Conductance Regulator -- adverse effectsTreatment OutcomeHumansUnited States
